A comprehensive view of U.S. Dept. of Health and Human Services (HHS). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

HHS ships monkeypox tests to five commercial laboratories to expand nation’s testing capacity, make tests more convenient, with testing ramping up through July; tests sent to Sonic Healthcare, Aegis Science, Labcorp, Mayo Clinic, Quest Diagnostics
Published: June 24, 2022 by Contify Life Science News
Jubilant gets US$146.6M contract from US HHS to double injectables filling capacity to meet demand for COVID-19 treatments; company spending US$193M total to add high-speed injectable fill line with 400 vial-per-minute capacity to be completed by 2025
Published: June 01, 2022 by FiercePharma
HHS reports sales of Pfizer’s COVID-19 oral antiviral Paxlovid outpaced drugs from other firms; 162,000 Paxlovid courses used in US in past week compared to 20,000 courses of Merck and Ridgeback’s Lagevrio, 16,000 courses of AstraZeneca’s Evusheld
Published: May 27, 2022 by FiercePharma
CMS proposes integrating equity, maternal health quality measures into proposed rule that drives hospital payments; proposed increase in operating payment to participating acute care hospitals paid under IPPS projected at 3.2%
Published: April 20, 2022 by U.S. Dept. of Health and Human Services (HHS)
Biogen urges CMS to reconsider decision to limit payment for FDA-approved injectable Aduhelm aducanumab-avwa 100 mg/mL to treat Alzheimer’s patients; Biogen states decision may limit coverage for future approved amyloid-beta targeting therapies
Published: April 08, 2022 by Biogen Inc.

Ask us about our Consumer Wellness market view

Trending Chart

Interactive chart with headline count